Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02640170 · ClinicalTrials.gov registry record
Intraoperative Imaging With ICG Registry
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 291
- Enrollment target
NCT02640170 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 291 participants.
The verdict
NCT02640170 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 291 participants
- Enrollment target
Study Summary
The purpose of this registry is to monitor the rate of recurrence in patients who undergo cancer surgery.
Interventions
- OTHER Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2016-07 |
| Est. Completion | 2020-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02640170
The ClinicalTrials.gov registry entry for NCT02640170 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Registry is the first listed.
NCT02640170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02640170 about?
NCT02640170 is a clinical study titled "Intraoperative Imaging With ICG Registry". The purpose of this registry is to monitor the rate of recurrence in patients who undergo cancer surgery.
What is the current status of trial NCT02640170?
This trial is currently completed. The enrollment target is 291 participants. The study started on 2016-07. Estimated completion is 2020-02.
What interventions are being tested in trial NCT02640170?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT02640170?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.